Samsung Biologics Co Ltd

207940.KS

$563.14

Closing

▼-0.90%

1D

▲1.32%

YTD

Market cap

$40.16B

52 week high

$643.59

52 week low

$488.54

Volume

43,061

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$40.16B

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

7

P/E

61.21

Operating Margin

32.60%

Beta

0.62

Revenue Growth (Annual)

-

52 week high

$643.59

52 week low

$488.54

Div. Yield

0.00%

EPS Annual Growth

22.80

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Samsung Biologics Co Ltd is a Korea-based company primarily engaged in development, manufacture and distribution of biological products. The Company, as a contract manufacturing organization (CMO), mainly develops and manufactures antibody drugs used for treatment of cancer, autoimmune disease, diabetes and chronic diseases. It also provides cell line development and process development services. The Company distributes its products in domestic and overseas markets.